Back to search

Ireland· IE-PA-EU/1/20/1465/001

Gencebok 10 mg/ml solution for infusion

A caffeine product containing caffeine + caffeine citrate, registered in Ireland by Gennisium Pharma. The same ATC class is registered in 15 of our 19 countries.

ATC N06BC01

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedGencebok 10 mg/ml solution for infusi…ATCN06BC01REGISTER NO.IE-PA-EU/1/20/1465/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Caffeine is registered in 15 of 19 countries.

Countries holding a registration under ATC N06BC01 (caffeine), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 8 of them publish a price we can compare per daily dose

Caffeine · ATC N06BC01

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Caffeine + Caffeine citrate
Manufacturer
Gennisium Pharma
Country
Ireland (IE)
ATC code
N06BC01
ATC class
Caffeine
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/20/1465/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

86 interactions on record for caffeine.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Caffeine · interactions on record

86 records

  • 5 severe
  • 45 moderate
  • 17 minor
  • 18 info

Most severe, free to view

  • TizanidineM03BX02severe
  • EsketamineN01AX14severe
  • CocaineN01BC01severe
  • EsketamineN06AX27severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Caffeine in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All caffeine products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Austria · Coffekapton
  • Belgium · Cafeine Sterop
  • Germany · Coffeinum N, Percoffedrinol N Aristo
  • Spain · Durvitan
  • France · Citrate De Cafeine Cooper, Percutafeine
  • United Kingdom (Northern Ireland) · Caffeine Citrate, Caffeine Citrate Brown & Burk Uk
  • Hungary · Coffeini Fono Viii. Naturland
  • Iceland · Gencebok, Peyona
  • Italy · Caffeina Citrato Monico
  • Liechtenstein · Gencebok, Peyona
  • Malta · Caffeine Citrate Monico
  • Norway · Gencebok, Peyona
  • Sweden · Koffein Viatris

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e98b8c0c-7722-4b97-adb5-05047cde091c
GET /v1/drugs/e98b8c0c-7722-4b97-adb5-05047cde091c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for infusion",
  "routes": [
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "N06BC01"
  ],
  "strength": null,
  "pa_number": "EU/1/20/1465/001",
  "substances": [
    "Caffeine",
    "Caffeine citrate"
  ],
  "legal_basis": "Hybrid application (Article 10(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "19/08/2020",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about caffeine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.